Speaker illustration

Doctor Mohammad Ali Mandegar

(United States of America)

Mo Mandegar is a senior scientist at Tenaya Therapeutics in San Francisco, California. At Tenaya, Mo has led drug discovery efforts using stem cell technology and phenotypic screening powered by artificial intelligence. His research efforts have resulted in the establishment of a pre-clinical program at Tenaya where the lead molecule is under the final stages of drug development.

Phenotypic screening identifies HDAC6 inhibitors as cardioprotective agents in BAG3 cardiac-knockout mouse model of dilated cardiomyopathy

Event: Heart Failure 2021

Topic: Systolic Ventricular Dysfunction

Session: ePoster session


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb